Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Omnicell stock
Learn how to easily invest in Omnicell stock.
Omnicell is a health information services business based in the US. Omnicell shares (OMCL) are listed on the NASDAQ and all prices are listed in US Dollars. Omnicell employs 4,160 staff and has a trailing 12-month revenue of around $1.3 billion.
How to buy Omnicell stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – OMCL. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Commission-free trading
- Commission-free crypto
- No minimum account balance
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Omnicell stock price (NASDAQ: OMCL)Use our graph to track the performance of OMCL stocks over time.
Omnicell shares at a glance
|Latest market close||$57.54|
|52-week range||$46.11 - $159.57|
|50-day moving average||$51.35|
|200-day moving average||$89.67|
|Wall St. target price||$71.40|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.92|
Buy Omnicell stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Omnicell stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Omnicell price performance over time
|1 week (2023-01-23)||-0.47%|
|1 month (2022-12-30)||14.12%|
|3 months (2022-10-28)||-26.19%|
|6 months (2022-07-27)||-47.84%|
|1 year (2022-01-28)||-61.18%|
|2 years (2021-01-29)||-51.15%|
|3 years (2020-01-30)||84.16|
|5 years (2018-01-29)||13.27%|
Is Omnicell stock undervalued or overvalued?
Valuing Omnicell stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Omnicell's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Omnicell's P/E ratio
Omnicell's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 59x. In other words, Omnicell shares trade at around 59x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Omnicell's PEG ratio
Omnicell's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.28. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Omnicell's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Omnicell's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $129.7 million.
The EBITDA is a measure of a Omnicell's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.3 billion|
|Operating margin TTM||5.46%|
|Gross profit TTM||$555 million|
|Return on assets TTM||2.11%|
|Return on equity TTM||4.28%|
|Market capitalisation||$2.4 billion|
TTM: trailing 12 months
Omnicell share dividends
We're not expecting Omnicell to pay a dividend over the next 12 months.
Omnicell share price volatility
Over the last 12 months, Omnicell's shares have ranged in value from as little as $46.11 up to $159.57. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Omnicell's is 0.9013. This would suggest that Omnicell's shares are less volatile than average (for this exchange).
Omnicell, Inc. , together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc.
Omnicell in the news
These 4 Toxic Stocks May Bring Bad Luck to Your Portfolio
Do Options Traders Know Something About Omnicell (OMCL) Stock We Don't?
What Does Omnicell, Inc.'s (NASDAQ:OMCL) Share Price Indicate?
Frequently asked questionsWhat percentage of Omnicell is owned by insiders or institutions?
Currently 1.408% of Omnicell shares are held by insiders and 106.777% by institutions. How many people work for Omnicell?
Latest data suggests 4,160 work at Omnicell. When does the fiscal year end for Omnicell?
Omnicell's fiscal year ends in December. Where is Omnicell based?
Omnicell's address is: 590 East Middlefield Road, Mountain View, CA, United States, 94043 What is Omnicell's ISIN number?
Omnicell's international securities identification number is: US68213N1090 What is Omnicell's CUSIP number?
Omnicell's Committee on Uniform Securities Identification Procedures number is: 68213N109
More guides on Finder
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert